Behavioral and Neurochemical Effects of Nociceptin/Orphanin FQ Receptor Activation in the Social Defeat Protocol

被引:5
|
作者
Camara, Alice Barros [1 ]
Brandao, Igor Augusto [2 ]
机构
[1] Univ Fed Rio Grande do Norte, Dept Biophys & Pharmacol, Av Sen Salgado Filho, BR-3000 Natal, RN, Brazil
[2] Univ Fed Rio Grande do Norte, Bioinformat Multidisciplinary Environm, Natal, RN, Brazil
关键词
NOP receptor; depression; animal model; social defeat protocol; oxidative stress; TAIL SUSPENSION TEST; OXIDATIVE STRESS; ORPHANIN-FQ; PHOSPHOLIPASE A(2); DEPRESSION; PEPTIDE; ANXIETY; MODEL; CULTURES; SYSTEM;
D O I
10.1037/bne0000539
中图分类号
B84 [心理学]; C [社会科学总论]; Q98 [人类学];
学科分类号
03 ; 0303 ; 030303 ; 04 ; 0402 ;
摘要
The nociceptin/orphanin FQ receptor (NOP receptor) has wide expression in the nervous system and is involved in neurotransmitter release. However, the role of the NOPR in depression is not widely recognized. This study aims to evaluate behavioral and biochemical effects of the NOPR agonist Ro 65-6570 in mice submitted to social defeat protocol. The open-field test, social interaction test, and tail suspension test were applied to evaluate depressive behavior in male Swiss mice. Blood and brain tissue samples were obtained to evaluate the oxidative stress. The NOP agonist, Ro 65-6570 (1 mg/kg), or the social defeat stress reduced exploration rate in the open-field test. The social defeat stress and/or the NOP agonist also increased immobility time in the tail suspension test and the grooming time, as well as reduced the social interaction on the last day of social defeat protocol. Seven days after the end of the protocol, only the drug alone was able to affect the animals' interaction. Additionally, the NOP agonist increased the concentration of carbonyl groups (CGs) in hippocampus and malondialdehyde in serum. The stress of social defeat and the NOP agonist, together, increased malondialdehyde in animals' serum and prefrontal cortex, as well as increased the CGs concentration in the prefrontal cortex. These findings indicate a chronic depressive effect induced by the NOPR activation, sometimes regardless of the social defeat stress. We suggest that the NOPR signaling can activate pathways involved in cellular oxidative stress, contributing to the depression pathology.
引用
收藏
页码:52 / 66
页数:15
相关论文
共 50 条
  • [41] Neurohumoral effects of orphanin FQ/nociceptin: relevance to cardiovascular and renal function
    Kapusta, DR
    PEPTIDES, 2000, 21 (07) : 1081 - 1099
  • [42] Further studies on the pharmacological features of the nociceptin/orphanin FQ receptor ligand ZP120
    Fischetti, Carmela
    Rizzi, Anna
    Gavioli, Elaine C.
    Marzola, Giuliano
    Trapella, Claudio
    Guerrini, Remo
    Petersen, Jorgen S.
    Calo, Girolamo
    PEPTIDES, 2009, 30 (02) : 248 - 255
  • [43] Stimulation of δ Opioid Receptor and Blockade of Nociceptin/Orphanin FQ Receptor Synergistically Attenuate Parkinsonism
    Mabrouk, Omar S.
    Viaro, Riccardo
    Volta, Mattia
    Ledonne, Ada
    Mercuri, Nicola
    Morari, Michele
    JOURNAL OF NEUROSCIENCE, 2014, 34 (39) : 12953 - 12962
  • [44] Antidepressant activity of nociceptin/orphanin FQ receptor antagonists in the mouse learned helplessness
    Victor A. D. Holanda
    Iris U. Medeiros
    Laila Asth
    Remo Guerrini
    Girolamo Calo’
    Elaine C. Gavioli
    Psychopharmacology, 2016, 233 : 2525 - 2532
  • [45] Synthesis, enantiomeric separation and docking studies of spiropiperidine analogues as ligands of the nociceptin/orphanin FQ receptor
    Battisti, Umberto M.
    Corrado, Sandra
    Sorbi, Claudia
    Cornia, Andrea
    Tait, Annalisa
    Malfacini, Davide
    Cerlesi, Maria Camilla
    Calo, Girolamo
    Brasili, Livio
    MEDCHEMCOMM, 2014, 5 (07) : 973 - 983
  • [46] Binding of GTPγ[35S] is regulated by GDP and receptor activation. Studies with the nociceptin/orphanin FQ receptor
    McDonald, John
    Lambert, David G.
    BRITISH JOURNAL OF PHARMACOLOGY, 2010, 159 (06) : 1286 - 1293
  • [47] Structure-and conformationactivity studies of nociceptin/orphanin FQ receptor dimeric ligands
    Pacifico, Salvatore
    Carotenuto, Alfonso
    Brancaccio, Diego
    Novellino, Ettore
    Marzola, Erika
    Ferrari, Federica
    Cerlesi, Maria Camilla
    Trapella, Claudio
    Preti, Delia
    Salvadori, Severo
    Calo, Girolamo
    Guerrini, Remo
    SCIENTIFIC REPORTS, 2017, 7
  • [48] Nociceptin/orphanin FQ opioid peptide-receptor expression in pachyonychia congenita
    Pan, Baohan
    Schroeder, Wolfgang
    Jostock, Ruth
    Schwartz, Mary
    Rosson, Gedge
    Polydefkis, Michael
    JOURNAL OF THE PERIPHERAL NERVOUS SYSTEM, 2018, 23 (04) : 241 - 248
  • [49] Synthesis and Structure-Activity Relationships of Triazaspirodecanone Derivatives as Nociceptin/Orphanin FQ Receptor Ligands
    Corrado, Sandra
    Battisti, Umberto M.
    Sorbi, Claudia
    Tait, Annalisa
    Malfacini, Davide
    Camarda, Valeria
    Calo, Girolamo
    Brasili, Livio
    CHEMICAL BIOLOGY & DRUG DESIGN, 2015, 86 (04) : 447 - 458
  • [50] Participation of the nociceptin/orphanin FQ receptor in ethanol-mediated locomotor activation and ethanol intake in preweanling rats
    Miranda-Morales, Roberto Sebastian
    Nizhnikov, Michael E.
    Waters, Dustin H.
    Spear, Norman E.
    BEHAVIOURAL BRAIN RESEARCH, 2013, 245 : 137 - 144